Leuprolide Acetate Injection

Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofLeuprolide Acetate Injectionfrom Surat, Gujarat, India. Leuprolide Acetate Injection used to treat prostate cancer, breast cancer, endometriosis,uterine fibroids, and early puberty, or as part of transgender hormone therapy.

Tags: Leuprolide Acetate Injection manufacturer, Leuprolide Acetate Injectionexporter, Leuprolide Acetate Injection supplier, and Leuprolide AcetateInjection, whogmp approved Leuprolide Acetate Injection manufacturer andsupplier, Leuprolide Acetate Injection distributor, Leuprolide Acetate Injectionshipper, Leuprolide Acetate Injection11.25 mgLeuprolide Acetate Injection11.25 mgsupplier, Leuprolide Acetate Injection11.25 mg.

ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.

Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.

Export Country:Saintroy LifescienceLeuprolide Acetate Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.